TCL Archive Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study March 30, 2007
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014
TCL Archive Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable April 26, 2013